Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
April 24, 2008
HTML PDF
Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
April 14, 2008
HTML PDF
Alexion Completes Enrollment in AEGIS Registration Study of Soliris® (eculizumab) in Patients with PNH in Japan
March 20, 2008
HTML PDF
Alexion to Present at Investor Conferences
March 11, 2008
HTML PDF
Alexion Acquires All Rights to OMRF Patents Related to Soliris®
February 14, 2008
HTML PDF
Alexion Reports Fourth Quarter and Full Year 2007 Results
February 14, 2008
HTML PDF
Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
January 28, 2008
HTML PDF
Alexion to Present at the Wachovia Securities 2008 Healthcare Conference
January 24, 2008
HTML PDF
Alexion Commences Dosing in AEGIS Registration Study of Soliris® (eculizumab) in Patients with PNH in Japan
January 7, 2008
HTML PDF
Alexion to Present at the 26th Annual JP Morgan Healthcare Conference
January 2, 2008
HTML PDF